Clémence M. Canivet

Author

Clémence M. Canivet

Also Known As

AFEF group for the study of liver fibrosis, C Canivet, C. Canivet, C. M. Canivet, C.M. Canivet, Canivet, Clémence, Clemence Canivet, Clemence M Canivet, Clemence M. Canivet, Clémence Canivet

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Inserm Université d'Angers Assistance Publique – Hôpitaux de Paris Centre Hospitalier Universitaire d'Angers Université Côte d'Azur

About

Clémence M. Canivet is an author at Inserm specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	317
2	Health Sciences	2	2	64
3	Engineering	1	1	28
4	Public Health	1	1	94
5	Clinical Nutrition	1	1	26

Clémence M. Canivet

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease Huapeng Lin, Hye Won Lee, Terry Cheuk‐Fung Yip, JAMA	2024	163
CD44 is a key player in non-alcoholic steatohepatitis Stéphanie Patouraux, Déborah Rousseau, Stéphanie Bonnafous, Journal of Hepatology Key PlayerMetabolic Associated SteatohepatitisHepatologyLiver PhysiologyImmunology	2017	124
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications Jérôme Boursier, Clémence M. Canivet, Charlotte Costentin, Clinical Gastroenterology and Hepatology Noninvasive TestsDiabetes ManagementLiver FibrosisHepatologyLiver Physiology	2022	94
Screening for therapeutic trials and treatment indication in clinical practice: <scp>MACK</scp>‐3, a new blood test for the diagnosis of fibrotic <scp>NASH</scp> Jérôme Boursier, Rodolphe Anty, Luisa Vonghia, Alimentary Pharmacology & Therapeutics	2018	73
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease Xiaodong Zhou, Seung Up Kim, Terry Cheuk‐Fung Yip, Gut	2024	64
Transient Versus Two‐Dimensional Shear‐Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD Christophe Cassinotto, Jérôme Boursier, Anita Paisant, Hepatology	2020	51
The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis A Sans, Stéphanie Bonnafous, Déborah Rousseau, Scientific Reports	2019	47
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD Clémence M. Canivet, Charlotte Costentin, Katharine M. Irvine, Hepatology	2022	42
Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver Clémence M. Canivet, Stéphanie Bonnafous, Déborah Rousseau, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Hepatic Fndc5Metabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2020	38
Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease Norma David, Jean‐Philippe Antignac, Marine Roux, Environment International	2023	32

Page 1